Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder
- 27 September 2010
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 63 (10), 910-915
- https://doi.org/10.1136/jcp.2010.079764
Abstract
Aim To construct a prognostic model for recurrence-free survival (RFS), progression-free survival (PFS) and cancer-specific survival (CSS) for patients who have undergone transurethral resection of non-muscle-invasive (pTa/pT1) urinary bladder urothelial tumours. Methods 1366 patients who had undergone transurethral resection of primary non-muscle-invasive urothelial tumours (pTa, 891 patients; pT1, 475 patients) confined to the bladder were retrospectively studied. Tumours were classified according to the 2004 WHO/International Society of Urologic Pathology grading system. Kaplan–Meier and stepwise Cox regression models were applied, and 200 bootstrap resamples were used to generate survival estimates and 95% CIs. A nomogram was developed that incorporated significant variables predicting survival. Results RFS, PFS and CSS probabilities for non-muscle-invasive bladder urothelial tumours were calculated. Incorporating salient prognostic factors (tumour grade, pT stage, patient age, status of intravesical instillation), the model satisfactorily predicted PFS (concordance index=0.79) and CSS (concordance index=0.87). Conclusions Robust nomograms were created to predict PFS and CSS. These data provide an overall perspective of disease outcomes which may aid in developing individualised follow-up programmes.Keywords
This publication has 12 references indexed in Scilit:
- Prognostic Significance of the 2004 WHO/ISUP Classification for Prediction of Recurrence, Progression, and Cancer-Specific Mortality of Non–Muscle-Invasive Urothelial Tumors of the Urinary BladderAmerican Journal of Clinical Pathology, 2010
- Predicting survival after radical cystectomy for bladder cancerBJU International, 2008
- Nomograms for Prediction of Disease Recurrence in Patients with Primary Ta, T1 Transitional Cell Carcinoma of the BladderJournal of Korean Medical Science, 2008
- Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomyCancer, 2007
- Survival Following the Diagnosis of Noninvasive Bladder Cancer: WHO/International Society of Urological Pathology Versus WHO Classification SystemsJournal of Urology, 2007
- Nomograms Provide Improved Accuracy for Predicting Survival after Radical CystectomyClinical Cancer Research, 2006
- Nomogram for Predicting Disease Recurrence After Radical Cystectomy for Transitional Cell Carcinoma of the BladderJournal of Urology, 2006
- Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder CancerJournal of Clinical Oncology, 2006
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 2005